Effect of Music Prehabilitation on Preoperative Anxiety Before Surgery
Launched by ERASMUS MEDICAL CENTER · Aug 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how listening to music before surgery can help reduce anxiety in patients with colon cancer who are scheduled for elective surgery. Participants in the trial will listen to music three times a day, starting one week before their surgery, to see if it makes them feel less anxious compared to a group that does not listen to music. The researchers will use questionnaires to measure anxiety levels before surgery.
To be eligible for this trial, patients need to be at least 16 years old and undergoing colorectal surgery at one of the participating centers. They should have a hospital stay of at least two days after surgery and be able to listen to music using their own device and headphones. Patients who have severe hearing issues, are professional musicians, or listen to music a lot already may not qualify. If you decide to participate, you will be asked to fill out some questionnaires about your anxiety, and your experience with the music will be part of the study. This research aims to find out if simple music listening can help make the surgical experience a little easier for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged ≥ 16 years
- • Patients undergoing elective oncological colorectal surgery at participating center
- • Minimal hospital stay of 2 days postoperatively.
- • Sufficient knowledge of the Dutch language
- • Communicable and able to assess the questionnaires
- • Patients who have access to personal music playing device and headphones/earphones. - Written informed consent acquired from the patient
- Exclusion Criteria:
- • Patients with severe hearing impairment (defined as no or barely verbal communication possible).
- • Patients with an expected stay of less than two nights in the hospital
- • Patients who are professional musicians.
- • Active music players or singers who may play or sing every week
- • Patients who actively listen to music with a duration of \> 30 minutes daily. Active listening is defined as music listening with headphones/earphones, while this is not combined with any other activity (e.g. exercising, working, driving or religious activities).
- • Patients who have a preoperative waiting period of less than five days.
- • Participation in another study that may possibly intervene with the outcome measures. (e.g. use of psychiatric medication during inclusion or prehabilitation interventions or similar procedures according to the judgement of the research team)
- • Assessment of primary outcome is not possible.
- • Patients with mental disorders influencing their ability to adhere to the study protocol and/or assess the questionnaires.
- • Inability or unwillingness to receive the music intervention.
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, Zuid Holland, Netherlands
Breda, Noord Brabant, Netherlands
Goes, Zeeland, Netherlands
Dordrecht, Zuid Holland, Netherlands
Rotterdam, Zuid Holland, Netherlands
Patients applied
Trial Officials
Markus Klimek, MD, PhD
Principal Investigator
Erasmus Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported